drugset / Trial / NCT01254383

Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Versus To Viagra® Oral Tablet.

NCT01254383

Phase 1 Completed 36 enrolled Viatris Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

This study will evaluate if an orally disintegrating tablet of sildenafil will have similar pharmacokinetic properties as the conventional tablet of sildenafil.

Timeline

Start
2010-12
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 50 mg Oral

Indications